9 Appendix I APPRAISAL OF GUIDELINES FOR RESEARCH & EVALUATION INSTRUMENT. The AGREE Collaboration
|
|
|
- Bruce Parks
- 5 years ago
- Views:
Transcription
1 9 Appendix I APPRAISAL OF GUIDELINES FOR RESEARCH & EVALUATION INSTRUMENT The AGREE Collaboration
2 September 2001 COPYRIGHT AND REPRODUCTION This document is the product of an international collaboration. It may be reproduced and used for educational purposes, quality assurance programmes and critical appraisal of clinical practice guidelines. It may not be used for commercial purposes or product marketing. Approved non-english language versions of the AGREE Instrument are being prepared, and must be used where available. Offers of assistance in translation into other languages are welcome, provided they conform to the protocol set out by the AGREE Collaboration. DISCLAIMER The AGREE Instrument is a generic tool designed primarily to help guideline developers and users assess the methodological quality of clinical practice guidelines. The authors do not take responsibility for the improper use of the AGREE Instrument. St George s Hospital Medical School, London, June 2001 Reprinted with amendments September 2001 ISBN X SUGGESTED CITATION: The AGREE Collaboration. Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument. FUNDING: The development of the AGREE Instrument was funded by a grant from the EU BIOMED2 Programme (BMH ) FOR FURTHER INFORMATION ABOUT THE INSTRUMENT CONTACT: Françoise Cluzeau f.cluzeau@sghms.ac.uk or Jako Burgers j.burgers@hsv.kun.nl Typeset by CA Group, London
3 Comments: 4 Strongly Agree. The guideline clearly describes the clinical imperative for the guideline and the overall purpose of the guidance. Additionally, Section 4 addresses the aim of the guideline and provides the details about groups covered, health care setting and clinical questions. Comments: 4 Strongly Agree. The questions addressed by the guideline are listed in section 4.5. Comments: 4 Strongly Agree. The patients for whom the guideline was written are identified in Sections 4.1, 4.2 and 4.3.
4 This deals with the potential health impact of a guideline on society and populations of patients. The overall objective(s) of the guideline should be described in detail and the expected health benefits from the guideline should be specific to the clinical problem. For example specific statements would be: Preventing (long term) complications of patients with diabetes mellitus; Lowering the risk of subsequent vascular events in patients with previous myocardial infarction; Rational prescribing of antidepressants in a cost-effective way. A detailed description of the clinical questions covered by the guideline should be provided, particularly for the key recommendations (see item 17). Following the examples provided in question 1: How many times a year should the HbA1c be measured in patients with diabetes mellitus? What should the daily aspirin dosage for patients with proven acute myocardial infarction be? Are selective serotonin reuptake inhibitors (SSRIs) more cost-effective than tricyclic antidepressants (TCAs) in treatment of patients with depression? There should be a clear description of the target population to be covered by a guideline. The age range, sex, clinical description, comorbidity may be provided. For example: A guideline on the management of diabetes mellitus only includes patients with non-insulin dependent diabetes mellitus and excludes patients with cardiovascular comorbidity. A guideline on the management of depression only includes patients with major depression, according to the DSM-IV criteria, and excludes patients with psychotic symptoms and children. A guideline on screening of breast cancer only includes women, aged between 50 and 70 years, with no history of cancer and with no family history of breast cancer. Comments: 4 - Strongly agree. The guideline development group was multidisciplinary and fully disclosed at the beginning of the guideline.
5 Comments: 4 Strongly Agree. The guideline development group included a patient representative. Comments: 4 Strongly Agree. The target users are described in Section 4.1. Comments: 1 Strongly Disagree. This guideline was not piloted. This item refers to the professionals who were involved at some stage of the development process. This may include members of the steering group, the research team involved in selecting and reviewing/rating the evidence and individuals involved in formulating the final recommendations. This item excludes individuals who have externally reviewed the guideline (see Item 13). Information about the composition, discipline and relevant expertise of the guideline development group should be provided.
6 Information about patients experiences and expectations of health care should inform the development of clinical guidelines. There are various methods for ensuring that patients perspectives inform guideline development. For example, the development group could involve patients representatives, information could be obtained from patient interviews, literature reviews of patients experiences could be considered by the group. There should be evidence that this process has taken place. The target users should be clearly defined in the guideline, so they can immediately determine if the guideline is relevant to them. For example, the target users for a guideline on low back pain may include general practitioners, neurologists, orthopaedic surgeons, rheumatologists and physiotherapists. A guideline should have been pre-tested for further validation amongst its intended end users prior to publication. For example, a guideline may have been piloted in one or several primary care practices or hospitals. This process should be documented. Comments: 4 Strongly Agree. The methodology was systematic and is clearly described in Section 5. Comments: 4 Strongly Agree. Selection criteria are well described in Section 5. Inclusion and exclusion criteria are clearly presented.
7 Comments: 4 Strongly Agree. Methods for formulating recommendations are well described in Section 5.5. Comments: 3 - Agree. Benefit and risk was considered by the GDG in making all recommendations (see Section 5.5). Methods for resolving differences within the GDG group are not described.
8 Comments: 4 Strongly Agree. Complete evidence summaries are presented in conjunction with the recommendations. Comments: 4 Strongly Agree. A peer review process was undertaken and completed before publication.
9 Comments: 4 Strongly Agree. The guideline update is scheduled for 2009.
10 Comments: 4 Strongly Agree. The recommendations are clear and are action oriented. Comments: 4 Strongly Agree. Options are given if appropriate. Comments: 4 Strongly Agree. The recommendations are presented in
11 Section 2 as well as within the results section for each patient group. Comments: 4 Strongly Agree. The following tools for implementation were developed: an algorithm, short version of guideline, quick reference guide for clinicians, information for patients leaflet and Web based material.
12 Comments: 4 Strongly Agree. These discussions are described in Section 11, Dissemination of the guideline. Comments: 1 Strongly Disagree. There is no economic analysis in this guideline. Comments: 4 Strongly Agree. Audit criteria are discussed in Section10 of this guideline.
13 Comments: 3 Agree. The funding source for this guideline is not explicitly
14 stated. However, the GDG is a diverse interdisciplinary group which includes a patient representative and is therefore likely to be independent, at least in part, from the funding body. Comments: 2 Disagree. This has not been explicitly stated. FURTHER COMMENTS OVERALL ASSESSMENT Strongly recommend
15 Recommend (with provisos or alterations): This guideline is recommended with following provisos: a. Update searches for the period from are carried out. b. Description of consensus methodology used for any Grade D recommendations is described. c. Conflict of interest records for GDG should be summarised. Would not recommend Unsure NOTES The AGREE Collaboration. Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument.
A critical appraisal of: Canadian guideline fysisk aktivitet using the AGREE II Instrument
A critical appraisal of: Canadian guideline fysisk aktivitet using the AGREE II Instrument Created with the AGREE II Online Guideline Appraisal Tool. No endorsement of the content of this document by the
Audit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57)
Audit support for continuous subcutaneous insulin (review of technology appraisal guidance 57) Issue date: 2008 Audit support Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus
CIHRT Exhibit P-2592 Page 1 APPENDIX. ADAPTE Process for the Treatment of In situ Breast Carcinoma. Eastern Health Breast Disease Site Group
CIHRT Exhibit P-2592 Page 1 APPENDIX ADAPTE Process for the Treatment of In situ Breast Carcinoma Eastern Health Breast Disease Site Group Phase I - Setup The Breast Disease Site Group was formed in the
Cochrane Breast Cancer Group
Cochrane Breast Cancer Group Version and date: V3.2, September 2013 Intervention Cochrane Protocol checklist for authors This checklist is designed to help you (the authors) complete your Cochrane Protocol.
National Cancer Peer Review Sarcoma. Julia Hill Acting Deputy National Co-ordinator
National Cancer Peer Review Sarcoma Julia Hill Acting Deputy National Co-ordinator Improving Outcomes Guidance The Intentions of Improving Outcomes for People with Sarcoma Changes in the provision of care
Reviewing the long-term use of selective serotonin reuptake inhibitors in patients with depression
CLINICAL AUDIT Reviewing the long-term use of selective serotonin reuptake inhibitors in patients with depression Valid to November 2022 bpac nz better medicin e Audit Focus This audit helps health professionals
Drug Misuse and Dependence Guidelines on Clinical Management
Department of Health Scottish Office Department of Health Welsh Office Department of Health and Social Services, Northern Ireland Drug Misuse and Dependence Guidelines on Clinical Management An Executive
Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)
Putting NICE guidance into practice Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Published: July 2014 This costing report accompanies Lipid modification:
TITLE: Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines
TITLE: Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines DATE: 08 May 2014 CONTEXT AND POLICY ISSUES Electroconvulsive therapy (ECT) is a treatment that
Assurance Engagements Other Than Audits or Reviews of Historical Financial Information
SINGAPORE STANDARD ON ASSURANCE ENGAGEMENTS SSAE 3000 (Revised) Assurance Engagements Other Than Audits or Reviews of Historical Financial Information The Singapore Standard on Auditing (SSA) 100 Assurance
MORECare: A framework for conducting research in palliative care
MORECare: A framework for conducting research in palliative care Nancy Preston International Observatory on End of Life Care School of Nursing, Midwifery and Social Work Methods for evaluating service
Management of depression
Primary Management of depression care in General Principles Most adults with depression present with mild depression and can be treated in primary care. The goal of treatment is to achieve remission of
Implementation Toolkit/Audit Form Splinting for the prevention and correction of contractures in adults with neurological dysfunction
Implementation Toolkit/ Splinting for the prevention and correction of contractures in adults with neurological dysfunction This audit form is to be used in conjunction with the evidence-based practice
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:
Measuring outcomes to improve the management of continence care. Dr Adrienne Rivlin KPMG Global Strategy Group
Measuring outcomes to improve the management of continence care Dr Adrienne Rivlin KPMG Global Strategy Group Background of the study Many treatment options, few find a cure High quality daily continence
The detection and management of pain in patients with dementia in acute care settings: development of a decision tool: Research protocol.
The detection and management of pain in patients with dementia in acute care settings: development of a decision tool: Research protocol. Aims and Objectives of the overall study The aim of this study
IPDAS Deliverables, Impact, & Next Steps
IPDAS Deliverables, Impact, & Next Steps 2003-2017 IPDAS Steering Committee: Dawn Stacey/Pending (Co-Leads), M Barry, N Col, A Coulter, M Härter, V Montori, N Moumjid, M Pignone, R Thomson, L Trevena,
Draft Accreditation Report for consultation
Guidance producer: Duchenne Muscular Dystrophy Care Considerations Working Group Guidance product: Diagnosis and Management of Duchenne Muscular Dystrophy guideline Date: 24 June 2011 Draft Accreditation
People with dementia and sight loss: a scoping study of models of care
Research findings October 2009 number 25 People with dementia and sight loss: a scoping study of models of care This publication summarises findings from a short scoping study conducted by Dr Ruth Bartlett
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
Expert Committee s Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report (1) Overview material Release Date December 2007 Status Available in
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Review of TA151 Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus This guidance was issued in
Trust Guideline for the inclusion of women at High Risk of Breast Cancer in the NHS Breast Screening Programme
Trust Guideline for the inclusion of women at High Risk of Breast Cancer in the NHS Breast Screening Programme For Use in: By: For: Division responsible for document: Key words: Name and job title of document
CJSP: On Reaffirming a Canadian School Psychology
748212CJSXXX10.1177/0829573517748212Canadian Journal of School PsychologyEditorial editorial2017 Editorial CJSP: On Reaffirming a Canadian School Psychology Canadian Journal of School Psychology 1 5 The
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Scope for Partial Update
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Scope for Partial Update 1 Guideline title Anxiety: management of generalised anxiety disorder in adults in primary, secondary and community care (update)
Unstable angina and NSTEMI
Issue date: March 2010 Unstable angina and NSTEMI The early management of unstable angina and non-st-segment-elevation myocardial infarction This guideline updates and replaces recommendations for the
Appraisal of Guidelines using the AGREE instrument
Appraisal of Guidelines using the AGREE instrument Asbjørn Jokstad How to appraise guidelines? Agree collaboration http://www.agreecollaboration.org 1 AGREE Instrument Appraisal instrument for clinical
Quality. Standards. Assurance. Summary Document. for physiotherapy service delivery. The Standards are organised into 10 sections:
Quality Summary Document See the full document at www.csp.org.uk/standards Assurance Standards for physiotherapy service delivery The Standards are organised into 10 sections: This leaflet provides a summary
Exposure Draft, ISA 720 (Revised) The Auditor s Responsibilities Relating to Other Information
Tel +44 (0)20 7694 8871 8 Salisbury Square Fax +44 (0)20 7694 8429 London EC4Y 8BB sylvia.smith@kpmgifrg.com United Kingdom Technical Director International Auditing and Assurance Standards Board International
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice Review of Clinical Guideline (CG54) - Urinary tract infection in children Background information Guideline issue date:
LEAF Marque Assurance Programme
Invisible ISEAL Code It is important that the integrity of the LEAF Marque Standard is upheld therefore the LEAF Marque Standards System has an Assurance Programme to ensure this. This document outlines
Summary of guideline for the. treatment of depression RANZCP CLINICAL PRACTICE GUIDELINES ASSESSMENT
RANZCP CLINICAL PRACTICE GUIDELINES Summary of guideline for the RANZCP CLINICAL PRACTICE GUIDELINES treatment of depression Pete M. Ellis, Ian B. Hickie and Don A. R. Smith for the RANZCP Clinical Practice
ADEA National Standards of Practice for Credentialled Diabetes Educators
ADEA National Standards of Practice for Credentialled Diabetes Educators Published 2003 Reviewed February 2014 Australian Diabetes Educators Association ABN 65 008 656 522 Chifley Health and Wellbeing
Guideline on the Regulation of Therapeutic Products in New Zealand
Guideline on the Regulation of Therapeutic Products in New Zealand Part 10: Requirements for information for prescribers and consumers Edition 7.0 January 2016 Section 1: Legislation Section summary This
The TECHNICAL SUPPORT UNIT of the IPCC Task Force on National Greenhouse Gas Inventories wishes to recruit a Head (1 Post)
The TECHNICAL SUPPORT UNIT of the IPCC Task Force on National Greenhouse Gas Inventories wishes to recruit a Head (1 Post) Position Head of the Technical Support Unit of the IPCC Task Force on National
Amendments to recommendations concerning venlafaxine
Amendments to recommendations concerning venlafaxine On 31 May 2006 the MHRA issued revised prescribing advice for venlafaxine*. This amendment brings the guideline into line with the new advice but does
ISA 540, Auditing Accounting Estimates, Including Fair Value Accounting Estimates, and Related Disclosures Issues and Task Force Recommendations
Agenda Item 1-A ISA 540, Auditing Accounting Estimates, Including Fair Value Accounting Estimates, and Related Disclosures Issues and Task Force Recommendations Introduction 1. Since the September 2016
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Diabetes dietary review Potential output: Recommendations
PRESCRIBING BY RADIOGRAPHERS: A VISION PAPER
PRESCRIBING BY RADIOGRAPHERS: A VISION PAPER 1 INTRODUCTION 1.1 The Review of Prescribing, Supply & Administration of Medicines (Crown II) Final Report was submitted to The Secretary of State for Health
Final Accreditation Report
Guidance producer: Uveal Melanoma Guideline Development Group Guidance product: Uveal Melanoma National Guidelines Date: 24 November 2014 Version: 1.3 Final Accreditation Report Uveal Melanoma Guideline
Dementia Priority Setting Partnership. PROTOCOL March 2012
Dementia Priority Setting Partnership PROTOCOL March 2012 Purpose The purpose of this protocol is to set out the aims, objectives and commitments of the Dementia Priority Setting Partnership (PSP) and
Re: Docket No. FDA D Presenting Risk Information in Prescription Drug and Medical Device Promotion
1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org August 25, 2009 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,
TITLE: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder.
Brief Summary TITLE: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. SOURCE(S): Practice parameters for the assessment and treatment
Dr Edward KoKoAung Master of Clinical Science School of Translational Science Faculty of Health Sciences The University of Adelaide South Australia.
The Association between Suicidality and Treatment with Selective Serotonin Reuptake Inhibitors in Older People with Major Depression: a Systematic Review Dr Edward KoKoAung Master of Clinical Science School
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Dementia: the management of dementia, including the use of antipsychotic medication in older people 1.1 Short title Dementia 2 Background
Consultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off
Policy For The Adjustment Of Insulin Injections By Paediatric Diabetes Specialist Nurses/Community Paediatric Nurses Diabetes Working With Children Within NHS Grampian Co-ordinators: Lead Paediatric Diabetes
What makes a good clinical guideline? Published by Hayward Medical Communications
Volume 1, number 11 What makes a good clinical guideline? Published by Hayward Medical Communications Rebecca Broughton RGN Evidence Based Practice Coordinator, Leicester Royal Infirmary NHS Trust Barrie
IAASB Main Agenda (March 2005) Page Agenda Item. DRAFT EXPLANATORY MEMORANDUM ISA 701 and ISA 702 Exposure Drafts February 2005
IAASB Main Agenda (March 2005) Page 2005 579 Agenda Item 13-F DRAFT EXPLANATORY MEMORANDUM ISA 701 and ISA 702 Exposure Drafts February 2005 Introduction This memorandum provides some background to, and
This follows similar work previously conducted by Bureau Veritas for Nestlé S.A. in other global operations.
Nestlé S.A. Independent Assurance of Compliance with the Nestlé Policy and Instructions for Implementation of the WHO International Code of Marketing of Breastmilk Substitutes in Colombia (May 2016) Independent
Critical Appraisal of a Clinical Practice Guideline
Critical Appraisal of a Clinical Practice Guideline Goal: To critically evaluate a guideline, using the Users Guides (reference below). Objectives: 1. Assess the validity of a guideline 2. Understand the
Consultation on renaming the Local anaesthetics and Prescription only medicines annotations for chiropodists / podiatrists
Consultation on renaming the Local anaesthetics and Prescription only medicines annotations for chiropodists / podiatrists 1. Introduction 1.1 We are the Health and Care Professions Council (HCPC). This
Evidence-based medicine and guidelines: development and implementation into practice
Evidence-based medicine and guidelines: development and implementation into practice PD Dr D. Aujesky, MSc MER Médecin-adjoint Service de Médecine Interne CHUV 1 Goals To discuss the basics of evidence-based
Application for Ethical Approval of Research Proposals
Application for Ethical Approval of Research Proposals Title of Research Researcher s Name Trinity Email Address Supervisor Name (if applicable) Supervisor Email (if applicable) Category of Proposer (please
Depression: management of depression in primary and secondary care
Issue date: December 2004, with amendments April 2007 Quick reference guide (amended) Depression: management of depression in primary and secondary care Amendment of recommendations concerning venlafaxine:
(See also General Regulations and Regulations for Taught Postgraduate Curricula)
D.29/817 REGULATIONS FOR THE DEGREE OF MASTER OF DENTAL SURGERY IN ENDODONTICS [MDS(Endo)] These regulations apply to candidates admitted in 2017-2018 and thereafter (See also General Regulations and Regulations
Treating Depression in Disadvantaged Women: What is the evidence?
Treating Depression in Disadvantaged Women: What is the evidence? Megan Dwight Johnson, MD MPH Associate Professor Medical Director, UWMC Inpatient Psychiatry Department of Psychiatry and Behavioral Sciences
BRIEF REPORTS. Effectiveness of a Smartphone App for Guiding Antidepressant Drug Selection Colin Man; Cathina Nguyen; Steven Lin, MD
Effectiveness of a Smartphone App for Guiding Antidepressant Drug Selection Colin Man; Cathina Nguyen; Steven Lin, MD BACKGROUND AND OBJECTIVES: Major depression is a prevalent chronic disease in the United
Delirium. Quick reference guide. Issue date: July Diagnosis, prevention and management
Issue date: July 2010 Delirium Diagnosis, prevention and management Developed by the National Clinical Guideline Centre for Acute and Chronic Conditions About this booklet This is a quick reference guide
Resource impact report: Sofosbuvir velpatasvir for treating chronic hepatitis C TA430
Putting NICE guidance into practice Resource impact report: Sofosbuvir velpatasvir for treating chronic hepatitis C TA430 Published: January 2017 Summary Sofosbuvir velpatasvir is recommended as an option
Q 2: Do you need training to use the ADI-R? If so, how can one access training and what does it cost?
1 Day 1 (February 5 th ) Q 1: Why use the ADI-R? A: The ADI-R is one of a number of available diagnostic instruments used for the diagnosis of autism/asd. It was first developed for research purposes but
See Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Rexulti) Reference Number: NE.PMN.68 Effective Date: 01/01/2017 Last Review Date: Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end of this
A proposal for collaboration between the Psychometrics Committee and the Association of Test Publishers of South Africa
A proposal for collaboration between the Psychometrics Committee and the Association of Test Publishers of South Africa 27 October 2015 Table of contents Introduction... 3 Overview of the Association of
Professional Development: proposals for assuring the continuing fitness to practise of osteopaths. draft Peer Discussion Review Guidelines
5 Continuing Professional Development: proposals for assuring the continuing fitness to practise of osteopaths draft Peer Discussion Review Guidelines February January 2015 2 draft Peer Discussion Review
THE JAMES LIND ALLIANCE Tackling treatment uncertainties together
An Introduction to THE JAMES LIND ALLIANCE Tackling treatment uncertainties together Summary Despite the vast amount of research on the effects of treatments in health care, many uncertainties remain.
Local Improvement Scheme (LIS) 2016/17 Local Service for Dementia Care in East Lancashire GP Practices
Local Improvement Scheme (LIS) 2016/17 Local Service for Dementia Care in East Lancashire GP Practices CONTENT Page number 1. Introduction 2 2. 5 key elements of the Dementia LIS 3 Practice Awareness Practice
COMPETENCES REQUIRED FOR APPLICANTS TO ATTAIN HPC REGISTRATION AS CLINICAL SCIENTISTS
This document comprises a discipline-specific version of the general competence document and provides additional guidance as to how to complete the general document, Appendix 1 of the Guidelines, that
CLINICAL AUDIT. Safe and Effective. Anticoagulation. with Warfarin
CLINICAL AUDIT Safe and Effective Anticoagulation with Warfarin Valid to September 2013 bpac nz better medicin e Focus of this audit This audit focuses on the safer prescribing of warfarin to help maintain
EFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY
Specialist details Patient identifier Name Tel: EFFECTIVE SHARE CARE AGREEMENT FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY The aim of Effective Shared Care Guidelines
Networking for success: A burning platform in Berkshire West
SERVICE REDESIGN CASE STUDY 1: NOVEMBER 2014 Networking for success: A burning platform in Berkshire West SUMMARY In 2012, four federated CCGs set up a network to redesign diabetes services in Berkshire
Costing Report: atrial fibrillation Implementing the NICE guideline on atrial fibrillation (CG180)
Putting NICE guidance into practice Costing Report: atrial fibrillation Implementing the NICE guideline on atrial fibrillation (CG180) Published: June 2014 This costing report accompanies the clinical
NZ Organised Stroke Rehabilitation Service Specifications (in-patient and community)
NZ Organised Stroke Rehabilitation Service Specifications (in-patient and community) Prepared by the National Stroke Network to outline minimum and strongly recommended standards for DHBs. Date: December
Clinical practice guideline on emergency management of acute apical periodontitis (AAP) in adults
Clinical practice guideline on emergency management of acute apical periodontitis (AAP) in adults This guideline has been developed by the Canadian Collaboration on Clinical Practice Guidelines in Dentistry
Psychotherapists and Counsellors Professional Liaison Group (PLG) 30 September 2010
Psychotherapists and Counsellors Professional Liaison Group (PLG) 30 September 2010 Information for organisations invited to present to meetings of the Psychotherapists and Counsellors Professional Liaison
NICE Indicator Programme. Consultation on proposed amendments to current QOF indicators
NICE Indicator Programme Consultation on proposed amendments to current QOF s Consultation dates: 18 July to 1 August 2018 This document outlines proposed amendments to a small number of QOF s in the diabetes
ECIBC overview. Donata LERDA Healthcare Quality Team leader
ECIBC overview Donata LERDA Healthcare Quality Team leader Joint Research Centre Institute for Health and Consumer Protection Public Health Policy Support Disclaimer: The contents of this presentation
Lincolnshire County Council: Councillors D Brailsford, S R Dodds, C E D Mair and Mrs M J Overton MBE.
1 PRESENT: COUNCILLOR C R OXBY (CHAIRMAN) LINCOLNSHIRE SAFEGUARDING BOARDS SCRUTINY SUB-GROUP Lincolnshire County Council: Councillors D Brailsford, S R Dodds, C E D Mair and Mrs M J Overton MBE. District
545 Fifth Avenue, 14th Floor Tel: +1 (212) New York, New York Fax: +1 (212) Internet:
Committee INTERNATIONAL FEDERATION OF ACCOUNTANTS 545 Fifth Avenue, 14th Floor Tel: +1 (212) 286-9344 New York, New York 10017 Fax: +1 (212) 856-9420 Internet: http://www.ifac.org Ethics Committee Meeting
The Society welcomes the opportunity to respond the Department of Health s consultation on generic substitution.
Lindsey Gilpin Chairman of the English Pharmacy Board Telephone: 020 7572 2519 Fax: 0207 572 2501 e-mail: howard.duff@rpsgb.org 25 th March 2010 Dear Sir/Madam, Consultation on the proposals to implement
Online Form. Welcome to the Integrated Research Application System. IRAS Project Filter
Welcome to the Integrated Research Application System IRAS Project Filter The integrated dataset required for your project will be created from the answers you give to the following questions. The system
Basis for Conclusions: ISA 530 (Redrafted), Audit Sampling
Basis for Conclusions: ISA 530 (Redrafted), Audit Sampling Prepared by the Staff of the International Auditing and Assurance Standards Board October 2008 , AUDIT SAMPLING This Basis for Conclusions has
Independent Assurance Statement by Bureau Veritas
Nestlé S.A. Independent Assurance of Compliance with the Nestlé Policy and Instructions for Implementation of the WHO International Code of Marketing of Breastmilk Substitutes in Kenya (May 2014) Independent
South East Coast Operational Delivery Network. Critical Care Rehabilitation
South East Coast Operational Delivery Networks Hosted by Medway Foundation Trust South East Coast Operational Delivery Network Background Critical Care Rehabilitation The optimisation of recovery from
Information about the Critically Appraised Topic (CAT) Series
Information about the Critically Appraised Topic (CAT) Series The objective of the Doctor of Nursing Practice (DNP) program at George Mason University is to prepare graduates for the highest level of nursing
Mental Health Intelligence Network
Mental Health Intelligence Network Consultation for Public Health England with mental health service users, families and others interested in mental health and wellbeing. Executive Summary June 2014 1
Independent Assurance Statement by Bureau Veritas
Nestlé S.A. Independent Assurance of Compliance with the Nestlé Policy and Instructions for Implementation of the WHO International Code of Marketing of Breastmilk Substitutes in Pakistan (August 2015)
NICE guidelines. Type 2 diabetes in adults: management
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NICE guidelines Equality impact assessment Type 2 diabetes in adults: management The impact on equality has been assessed during guidance development according
Audit and Implementation Guide: Clinical guidelines for the pre and post operative physiotherapy management of adults with lower limb amputations
2nd Edition- 2016 Audit and Implementation Guide: Clinical guidelines for the pre and post operative physiotherapy British Association of Chartered Physiotherapists in Amputee Rehabilitation NICE has accredited
National Standards for Diabetes Education Programs
National Standards for Diabetes Education Programs Australian Diabetes Educators Association Established 1981 National Standards For Diabetes Education Programs - ADEA 2001 Page 1 Published July 2001 by
400 Hour Evaluation of Student Learning Form Concordia University Social Work Practicum Program
400 Hour of Student Learning Form Concordia University Social Work Practicum Program Date: Name Name Agency Name This evaluation is intended to help monitor the student s development of professional practice
Standard Methods for Quality Assessment of Evidence
Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301 1079 Phone 503 947 5220 Fax 503 947 1119 Standard Methods for Quality Assessment of Evidence
Clinical Policy: Clomipramine (Anafranil) Reference Number: HIM.PA.149 Effective Date: Last Review Date: 05.18
Clinical Policy: (Anafranil) Reference Number: HIM.PA.149 Effective Date: 03.13.18 Last Review Date: 05.18 Line of Business: HIM Revision Log See Important Reminder at the end of this policy for important
Measuring the impact of patient and public involvement in the JLA Kidney Transplant PSP
Measuring the impact of patient and public involvement in the JLA Kidney Transplant PSP Contents Measuring the impact of patient and public involvement in the JLA Kidney Transplant PSP... 1 Overview and
Health care guidelines, recommendations, care pathways
II European Reference Network Conference From planning to implementation Lisbon, 8-9 October 2015 Health care guidelines, recommendations, care pathways Paola Laricchiuta National Centre for Rare Diseases
Ratified by: Care and Clinical Policies Date: 17 th February 2016
Clinical Guideline Reference Number: 0803 Version 5 Title: Physiotherapy guidelines for the Management of People with Multiple Sclerosis Document Author: Henrieke Dimmendaal / Laura Shenton Date February
JICPA comments on the IESBA Exposure Draft, Proposed Revisions to the Code Pertaining to the Offering and Accepting of Inducements
The Japanese Institute of Certified Public Accountants 4-4-1 Kudan-Minami, Chiyoda-ku, Tokyo 102-8264, Japan Phone: 81-3-3515-1130 Fax: 81-3-5226-3355 Email: international@sec.jicpa.or.jp December 8, 2017
Search thi. Search. CPD profile. 1.1 Profession: PHYSIOTHERAPY. 1.2 CPD number: CPD (PH35838)
Cymraeg Search: Search thi Search CPD profile 1.1 Profession: PHYSIOTHERAPY 1.2 CPD number: CPD004635 (PH35838) The Process Random selection for CPD profile to demo activities in last 2 years to meet
Clinical guideline Published: 28 October 2009 nice.org.uk/guidance/cg91
Depression in adults with a chronic physical health problem: recognition and management Clinical guideline Published: 28 October 2009 nice.org.uk/guidance/cg91 NICE 2018. All rights reserved. Subject to
Assessment. Jo Winther
Assessment Jo Winther Overview What is clinical assessment Mindful four session assessment model RCHIMHS Assessment Project What does the service data say? What should a comprehensive assessment look like?
COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
The European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 15 December 2005 EMEA/357981/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON PROCEDURES
Patient and public involvement. Guidance for researchers
Patient and public involvement Guidance for researchers Contents What is patient and public involvement and why is it important? 3 Benefits of patient and public involvement for researchers 4 Levels of
This is the publisher s version. This version is defined in the NISO recommended practice RP
Journal Article Version This is the publisher s version. This version is defined in the NISO recommended practice RP-8-2008 http://www.niso.org/publications/rp/ Suggested Reference Chong, J., Karner, C.,